Brief: 60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment
21/11/2025 13:26
Nov 21 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O: 60 DEGREES PHARMACEUTICALS ANNOUNCES CLINICAL SITE NOW OPEN FOR PATIENT ENROLLMENT FOR THE B-FREE CHRONIC BABESIOSIS STUDY AT MOUNT SINAI ICAHN SCHOOL OF MEDICINE Source text: ID:nGNX89TBtK Further company coverage: SXTP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 60 Degrees Pharmaceuticals
See all newsBrief: 60 Degrees Pharmaceuticals Says May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028 - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM